Advances in Clinical Chemistry and Laboratory Medicine

Book

Advances in Clinical Chemistry and Laboratory Medicine

Edited by: Harald Renz and Rudolf Tauber

Language: English

Published/Copyright: 2012

Published by

Become an author with De Gruyter Brill

Explore this Subject How to publish with us

About this book

This volume comprises the invited plenary lectures and contributed papers presented at the WorldMedLab and the EuroMedLab in Berlin, May 2011 with more than 5.000 participants. The contributions in this volume provide a valuable and wide-ranging overview of current research in Laboratory Medicine and cognate disciplines. Special focus is given to Aging Society (neurological diseases), Tumors, Organ specific dysfunctions and Future of Laboratory Medicine.

comprises the invited plenary lectures and contributed papers presented at the WorldMedLab and the EuroMedLab in Berlin, May 2011
provides a valuable and wide-ranging overview of current research in Laboratory Medicine and cognate disciplines
special focus is given to Aging Society (neurological diseases), Tumors, Organ specific dysfunctions and Future of Laboratory Medicine

Author / Editor information

Harald Renz, University of Marburg, Germany; Rudolf Tauber, Charité, Berlin, Germany.

Topics

Frontmatter Requires Authentication Unlicensed Licensed Download PDF	i
Preface Requires Authentication Unlicensed Licensed Download PDF	v
Table of Contents Requires Authentication Unlicensed Licensed Download PDF	vii
Authors Index Requires Authentication Unlicensed Licensed Download PDF	xi
1 Plenary Articles
1.1 Proteomics strategies targeting biomarkers for cardiovascular disease Arjen Scholten and Albert J.R. Heck Requires Authentication Unlicensed Licensed Download PDF	3
1.2 Influence of pre-examination aspects on result’s validity – are ISO 15189 requirements sufficient and clear? Luděk Šprongl Requires Authentication Unlicensed Licensed Download PDF	9
1.3 Posttranslational modifications in tumor diagnosis Peter Nollau and Christoph Wagener Requires Authentication Unlicensed Licensed Download PDF	12
1.4 Chronic inflammatory disease: a result of complex gene-environment interaction Harald Renz, Petra Ina Pfefferle and Holger Garn Requires Authentication Unlicensed Licensed Download PDF	16
2 Symposium Articles
2.1 Component-array technology diagnostics: a step forward in the study of the sensitization profile of allergic patients Juan Manuel Acedo Sanz Requires Authentication Unlicensed Licensed Download PDF	23
2.2 Pediatric metabolic syndrome: pathophysiology and molecular mechanisms Julie Chemin and Khosrow Adeli Requires Authentication Unlicensed Licensed Download PDF	26
2.3 Urinary 8-hydroxydeoxyguanosine as a biomarker of microangiopathic complications in type 2 diabetic patients Amr Fattouh, Nermine H. Mahmoud, Shereen H. Atef and Abd El Rahman Gaber Requires Authentication Unlicensed Licensed Download PDF	30
2.4 Biological variation data: the need for appraisal of the evidence base William A. Bartlett Requires Authentication Unlicensed Licensed Download PDF	35
2.5 Recovery ELISA – a newly-developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy Pavel Strohner, Dieter Sarrach, Jens G. Reich, Antonia Staatz, Astrid Schäfer, Jens-Oliver Steiß, Thomas Häupl and Gunther Becher Requires Authentication Unlicensed Licensed Download PDF	38
2.6 Genotypic prediction of HIV-1 tropism from plasma and peripheral blood mononuclear cells in the clinical routine laboratory Christian Paar, Maria Geit, Herbert Stekel and Jörg Berg Requires Authentication Unlicensed Licensed Download PDF	42
2.7 Expression of a subset of microRNAs in clinically non-functioning pituitary adenomas correlates with tumor size Henriett Butz, István Likó, Sándor Czirják, Péter Igaz, Márta Korbonits, Károly Rácz and Attila Patócs Requires Authentication Unlicensed Licensed Download PDF	46
2.8 Serological markers of gastric pathology Alberta Caleffi Requires Authentication Unlicensed Licensed Download PDF	50
2.9 BNP as a biomarker of cardiac impairment in neonates with congenital heart diseases Massimiliano Cantinotti, Bruno Murzi, Simona Storti and Aldo Clerico Requires Authentication Unlicensed Licensed Download PDF	54
2.10 Are 25-hydroxyvitamin D assays fit for purpose? Graham D. Carter Requires Authentication Unlicensed Licensed Download PDF	58
2.11 Update on multiple sclerosis Anne H. Cross Requires Authentication Unlicensed Licensed Download PDF	61
2.12 Microalbuminuria and urinary retinol binding protein as markers of subtle renal injury in visceral leishmaniasis: sensitivity, specificity and predictive values of the immunoturbidimetric technique Nuha A.A. Elnojomi, Ahmed M. Musa, Brima M. Younis, Mohammed E. Elfaki, Ahmed M. El-Hassan and Eltahir A. Khalil Requires Authentication Unlicensed Licensed Download PDF	65
2.13 Occult hepatitis B virus infection: diagnosis and significance Wolfram Hubert Gerlich, Christian Gisbert Schüttler and Dieter Glebe Requires Authentication Unlicensed Licensed Download PDF	68
2.14 Unmet needs in chronic kidney disease testing Graham Jones Requires Authentication Unlicensed Licensed Download PDF	72
2.15 Towards a national chronic kidney disease testing program Graham Jones Requires Authentication Unlicensed Licensed Download PDF	75
2.16 Biochemistry and metabolism of vitamin D Glenville Jones Requires Authentication Unlicensed Licensed Download PDF	78
2.17 Diagnostics of thalassemia Martha Kaeslin, Saskia Brunner-Agten and Andreas R. Huber Requires Authentication Unlicensed Licensed Download PDF	82
2.18 The specific roles of assessors during accreditation Wim Huisman Requires Authentication Unlicensed Licensed Download PDF	85
2.19 Laboratory diagnosis of hereditary spherocytosis May-Jean King Requires Authentication Unlicensed Licensed Download PDF	88
2.20 Quantification of blood folate forms using stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry Susanne H. Kirsch, Wolfgang Herrmann and Rima Obeid Requires Authentication Unlicensed Licensed Download PDF	91
2.21 Evaluation of the new Marburg cerebrospinal fluid model with human spondylopathies Tilmann Otto Kleine, Christa Löwer, Siegfried Bien, Reinhardt Lehmitz and Alexandra Dorn-Beineke Requires Authentication Unlicensed Licensed Download PDF	95
2.22 E-learning experiences of national societies of clinical chemistry and laboratory medicine Petr Kocna Requires Authentication Unlicensed Licensed Download PDF	99
2.23 The experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings Cara S. Kosack Requires Authentication Unlicensed Licensed Download PDF	102
2.24 Screening, identifying, and quantifying small molecules by hyphenated mass spectrometry in toxicology and drug monitoring – an update Hans H. Maurer Requires Authentication Unlicensed Licensed Download PDF	108
2.25 Analytical quality in the Latin America area Gabriel Alejandro Migliarino Requires Authentication Unlicensed Licensed Download PDF	111
2.26 Standardization in molecular diagnostics: definitions and uses of nucleic acid reference materials Deborah A. Payne, François Rousseau, Cyril D.S. Mamotte, David Gancberg, Ron H.N. van Schaik, Heinz Schimmel and Mario Pazzagli Requires Authentication Unlicensed Licensed Download PDF	116
2.27 Profiling of antiphospolipid antibodies – association with cerebrovascular events in APS Dirk Roggenbuck Requires Authentication Unlicensed Licensed Download PDF	120
2.28 Plasma levels of soluble CD30 and CD40L in pediatric patients after liver transplantation Olga P. Shevchenko, Olga M. Tsirulnikova, Olga E. Gichkun, Rivada M. Kurabekova, Aleksandr A. Ammosov and Sergey V. Gautier Requires Authentication Unlicensed Licensed Download PDF	124
2.29 Diagnostic and prognostic value of presepsin (soluble CD14 subtype) in emergency patients with early sepsis using the new assay PATHFAST presepsin Eberhard Spanuth, Henning Ebelt, Boris Ivandic and Karl Werdan Requires Authentication Unlicensed Licensed Download PDF	128
2.30 Diagnostic workup of primary aldosteronism Michael Stowasser Requires Authentication Unlicensed Licensed Download PDF	134
2.31 What should the clinical laboratory and the toxicologist-pharmacologist offer the poisoned patient? Donald R.A. Uges Requires Authentication Unlicensed Licensed Download PDF	138
2.32 Novel aspects of the von Willebrand factor – platelet glycoprotein IB interaction and signaling Ulrich Walter, Stepan Gambaryan, Sabine Herterich and Suzanne M. Lohmann Requires Authentication Unlicensed Licensed Download PDF	142
2.33 Medical emergencies: what is the laboratory’s role? Donald S. Young Requires Authentication Unlicensed Licensed Download PDF	143

Publishing information

Pages and Images/Illustrations in book

eBook published on:

October 1, 2012

eBook ISBN:

9783110224641

Hardcover published on:

September 14, 2012

Hardcover ISBN:

9783110224634

Pages and Images/Illustrations in book

Front matter:

18

Main content:

145

Illustrations:

30

Tables:

20

https://doi.org/10.1515/9783110224641

eBook ISBN: 9783110224641

Hardcover ISBN: 9783110224634

Keywords for this book

Haematology; Clinical Chemistry; Laboratory Diagnostics; Laboratory Medicine; Pathobiochemistry

Audience(s) for this book

Laboratory Physicians, Clinical Chemists

Safety & product resources

Manufacturer information:
Walter de Gruyter GmbH
Genthiner Straße 13
10785 Berlin
productsafety@degruyterbrill.com

Advances in Clinical Chemistry and Laboratory Medicine

Overview

About this book

Author / Editor information

Topics

Table of contents

Bibliographic data